Abbott Laboratories

Find Ratings Reports
ABT : NYSE : Health Care
$44.13 | %
Today's Range: 0.0 - 0.0
Avg. Daily Volume: 7795700.0
04/24/17 - 4:02 PM ET

Financial Analysis

ABBOTT LABORATORIES's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company has grown sales and net income significantly, outpacing the average growth rates of competitors within its industry.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)6335.04885.0
EBITDA ($mil)0.0987.0
EBIT ($mil)667.0640.0
Net Income ($mil)419.0316.0

Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)0.03957.0
Total Assets ($mil)0.039637.0
Total Debt ($mil)0.08590.0
Equity ($mil)0.020722.0

Profitability Q1 FY17 Q1 FY16
Gross Profit Margin51.060.92
EBITDA Margin0.020.2
Operating Margin10.5313.1
Sales Turnover0.00.51
Return on Assets0.06.17
Return on Equity0.010.29
Debt Q1 FY17 Q1 FY16
Current Ratio0.01.48
Interest Expense0.046.0
Interest Coverage0.013.91

Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)0.01469.15
Div / share0.270.26
Book value / share0.014.1
Institutional Own % n/a n/a
Avg Daily Volume7753854.08907966.0


BUY. This stock's P/E ratio indicates a premium compared to an average of 44.36 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.92.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ABT 49.42 Peers 44.36   ABT NA Peers 26.92

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

ABT is trading at a premium to its peers.


Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
ABT 15.93 Peers 32.13   ABT 0.20 Peers 1.15

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ABT is trading at a significant discount to its peers.


Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ABT trades at a significant discount to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ABT NA Peers 4.93   ABT -36.88 Peers 99.98

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

Ratio not available.


Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ABT is expected to significantly trail its peers on the basis of its earnings growth rate.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ABT NA Peers 4.94   ABT 9.36 Peers 14.96

Neutral. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

Ratio not available.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ABT significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades